When the largest Japanese pharmaceutical innovator company, Daiichi Sankyo acquired Ranbaxy Laboratories in June 2008 in a $4.6 billion deal,…
Did you know that James Cameron, the award-winning film director, producer and screenwriter, worked as a truck driver and a…
India is currently being made a target for cyberwar. No sooner did the news of the recent hacking of an…
India?s cyberspace is fast becoming a volatile place to be in. Much to the despise of the Indian Computer Emergency
Tech multinationals? research and development gravity is fast shifting from the West to the East. Their developer ….
Notwithstanding hopes or fears, nanotechnology is finally moving beyond the confines of the research laboratories to the marketplace.
As the global recession ebbs away, Indian IT-BPO, pharmaceuticals and biotech industries are hoping for the…
Pharmaceutical companies are writing a new prescription for growth in the $8.4 billion domestic pharmaceuticals market.
The $20 billion global vaccine industry is sitting on a tough decision. Industry is debating whether it is time to…
Stem cell banking and therapy is making its presence felt in the country. About 1,500 people are opting to store…
The Council of Scientific and Industrial Research?s open source drug discovery programme seems to have hit a rough patch. Even…
Thanks to the recent completion of first ever human genome sequencing in India by scientists at the Institute of Genomics…
The $42 billion global clinical trials and data management market seems to be accelerating its move to India. As the…
If generics are the gateway of growth for global pharmaceutical giants such as AstraZeneca, Pfizer, Sanofi-Aventis, Novartis, Merck and GlaxoSmithKline,…
Uncovering new ways to treat diseases from increasing biological data remains a daunting task for a life sciences researcher. With…
Indian pharmaceutical industry?s bold efforts to foray into the high profile yet highly risky drug discovery arena seem to have…
Are you worried about the safety of your medicines? You have every reason to be. Chances are the most frequently…
Global pharmaceutical majors are not getting healthy indicators from the $8 billion domestic pharmaceutical market, especially on the intellectual property…
